JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Arrhythmia Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arrhythmias, Cardiac", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Duke University Medical Center, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.414179.e", 
          "name": [
            "Department of Medicine, Duke University Medical Center, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nair", 
        "givenName": "Lawrence A.", 
        "id": "sg:person.0742051110.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742051110.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Duke University Medical Center, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.414179.e", 
          "name": [
            "Department of Medicine, Duke University Medical Center, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grant", 
        "givenName": "Augustus O.", 
        "id": "sg:person.01130565260.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130565260.31"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00877629", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032432823", 
          "https://doi.org/10.1007/bf00877629"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00877626", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006392561", 
          "https://doi.org/10.1007/bf00877626"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00581631", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035526856", 
          "https://doi.org/10.1007/bf00581631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01258466", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031359380", 
          "https://doi.org/10.1007/bf01258466"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00878513", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022359332", 
          "https://doi.org/10.1007/bf00878513"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4615-7858-1_9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016316955", 
          "https://doi.org/10.1007/978-1-4615-7858-1_9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1997-04", 
    "datePublishedReg": "1997-04-01", 
    "description": "The goal of developing an antiarrhythmic agent effective against malignant ventricular arrhythmias while maintaining a low side-effect profile remains elusive. The class III drugs amiodarone and sotalol are the best available agents. However, both drugs possess properties outside the realm of a pure class III effect, and their use is limited by a variety of dose-related side effects. There are several drugs with more selective class III properties currently in development. This review provides an overview of the optimal characteristics of an effective theoretical class III drug and a summary of the properties of a number of class III drugs under active investigation. An ideal class III antiarrhythmic agent for a reentrant arrhythmia should provide use-dependent prolongation of the action potential duration with slow onset and rapid offset kinetics. This drug would prolong the effective refractory period of cardiac tissue selectively at the rapid heart rates achieved during ventricular tachycardia or fibrillation with a delayed onset of action, and a rapid resolution of its effects on resumption of physiologic heart rates. With little effect on the refractory period at normal or slow heart rates, the ability to induce torsade de pointes would be lessened. In contrast to these ideal properties, most currently available and investigational agents have a reverse use-dependent effect on the action potential duration, producing more effects on the refractory period at slower heart rates. This property results in part from preferential block of the rapidly activating component of the delayed rectifier potassium channel (I_Kr), with little or no effect on the slowly activating component (I_Ks). The development of a drug with favorable blocking kinetics that selectively blocks I_Ks may result in lower proarrhythmic events while still maintaining effective antiarrhythmic properties.", 
    "genre": "article", 
    "id": "sg:pub.10.1023/a:1007784814823", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2531253", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097576", 
        "issn": [
          "0920-3206", 
          "1573-7241"
        ], 
        "name": "Cardiovascular Drugs and Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "keywords": [
      "class III antiarrhythmic agent", 
      "slower heart rate", 
      "action potential duration", 
      "heart rate", 
      "antiarrhythmic agents", 
      "class III drugs", 
      "refractory period", 
      "potential duration", 
      "low side effect profile", 
      "reverse use-dependent effects", 
      "dose-related side effects", 
      "best available agents", 
      "use-dependent prolongation", 
      "side effect profile", 
      "class III effects", 
      "malignant ventricular arrhythmias", 
      "onset of action", 
      "effective refractory period", 
      "use-dependent effects", 
      "rapid heart rate", 
      "class III properties", 
      "rectifier potassium channel", 
      "mechanism of action", 
      "proarrhythmic events", 
      "ventricular arrhythmias", 
      "proarrhythmic potential", 
      "investigational agents", 
      "ventricular tachycardia", 
      "antiarrhythmic properties", 
      "offset kinetics", 
      "rapid resolution", 
      "physiologic heart rates", 
      "preferential block", 
      "available agents", 
      "slow onset", 
      "side effects", 
      "drug amiodarone", 
      "reentrant arrhythmias", 
      "potassium channels", 
      "drugs", 
      "cardiac tissue", 
      "III effects", 
      "active investigation", 
      "arrhythmias", 
      "onset", 
      "agents", 
      "duration", 
      "torsades", 
      "amiodarone", 
      "tachycardia", 
      "pointes", 
      "fibrillation", 
      "sotalol", 
      "period", 
      "prolongation", 
      "rate", 
      "effect", 
      "little effect", 
      "tissue", 
      "action", 
      "resumption", 
      "review", 
      "more effect", 
      "development", 
      "summary", 
      "events", 
      "contrast", 
      "profile", 
      "mechanism", 
      "use", 
      "ability", 
      "optimal characteristics", 
      "components", 
      "number", 
      "ideal properties", 
      "investigation", 
      "potential", 
      "overview", 
      "variety", 
      "characteristics", 
      "goal", 
      "part", 
      "block", 
      "kinetics", 
      "channels", 
      "resolution", 
      "properties", 
      "realm"
    ], 
    "name": "Emerging Class III Antiarrhythmic Agents:Mechanism of Action and Proarrhythmic Potential", 
    "pagination": "149-167", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043450659"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1007784814823"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9140692"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1007784814823", 
      "https://app.dimensions.ai/details/publication/pub.1043450659"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_267.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1023/a:1007784814823"
  }
]

Download the RDF metadata as:  json-ld nt turtle xml License info

This table displays all metadata directly associated to this object as RDF triples.

202 TRIPLES      21 PREDICATES      125 URIs      110 LITERALS      11 BLANK NODES